[77] With respect to the outcome, which has improved treatment efficacy compare with those without cetuximab, and side effects were also manageable and endurable.[79] Other EGFR antibody, such as gefitinib, lapatinib, were also used in the treatment of metastatic salivary gland cancer, particularly in ACC. The gene discussed is EGFR; the disease is adrenal cortex carcinoma.